CompoAtlas

Adréno process - soir

Food supplement declared in France, decision dated 30 October 2025

Adréno process - soir is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
LAB. O2&VIE SAS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
Prendre 2 gélules par jour
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes

Declaration 344837, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Mucuna pruriens (L.) DC.GraineExtrait sec hydroalcoolique200 mg
Panax ginseng C.A.Mey.RacinePoudre (de plantes séchées ou broyées)160 mg
Styphnolobium japonicum (L.) SchottFeuilleExtrait sec hydroalcoolique100 mg
Ribes nigrum L.FeuillePoudre (de plantes séchées ou broyées)80 mg

Substances

NamePer day
tyrosine59 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé aux adultes. Déconseillé en cas d’insuffisance cardiaque ou rénale œdèmateuses, aux femmes enceintes et allaitantes et chez les personnes sous traitement antidiabétique. Prendre l'attache d'un professionnel de santé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line